Suppr超能文献

微小RNA-330-3p通过靶向丝裂原活化蛋白激酶激酶1抑制肝癌细胞迁移。

miR-330-3p suppresses liver cancer cell migration by targeting MAP2K1.

作者信息

Jin Zhe, Jia Baoxing, Tan Ludong, Liu Yahui

机构信息

Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.

出版信息

Oncol Lett. 2019 Jul;18(1):314-320. doi: 10.3892/ol.2019.10280. Epub 2019 Apr 24.

Abstract

MicroRNAs, considered as a promising focus for the treatment of tumors, are key regulators of a large number of genes. The aim of the present study was to investigate the biological functions of microRNA (miR)-330-3p in liver cancer as it had been identified previously that miR-330-3p was deregulated in liver cancer. In order to identify the function of miR-330-3p in liver cancer, the expression of miR-330-3p was determined in liver cancer tissues and adjacent non-tumor tissues using reverse transcription-quantitative polymerase chain reaction analysis. To elucidate the function of miR-330-3p in liver cancer, miR-330-3p was overexpressed using mimic transfection. Cell migration was inhibited by miR-330-3p in liver cancer cells. The miRNA target prediction databases were used to identify potential target genes of miR-330-3p in liver cancer. The RNA level of mitogen-activated protein kinase kinase 1 (MAP2K1) was downregulated by miR-330-3p in liver cancer cells. In conclusion, miR-330-3p suppresses cell migration by targeting MAP2K1 in liver cancer cells.

摘要

微小RNA被认为是肿瘤治疗的一个有前景的研究重点,是大量基因的关键调节因子。本研究的目的是探讨微小RNA(miR)-330-3p在肝癌中的生物学功能,因为先前已发现miR-330-3p在肝癌中表达失调。为了确定miR-330-3p在肝癌中的功能,采用逆转录-定量聚合酶链反应分析方法检测肝癌组织及癌旁非肿瘤组织中miR-330-3p的表达。为了阐明miR-330-3p在肝癌中的功能,通过模拟转染使miR-330-3p过表达。miR-330-3p抑制肝癌细胞的迁移。利用微小RNA靶标预测数据库鉴定肝癌中miR-330-3p的潜在靶基因。在肝癌细胞中,miR-330-3p下调丝裂原活化蛋白激酶激酶1(MAP2K1)的RNA水平。总之,miR-330-3p通过靶向肝癌细胞中的MAP2K1抑制细胞迁移。

相似文献

1
miR-330-3p suppresses liver cancer cell migration by targeting MAP2K1.
Oncol Lett. 2019 Jul;18(1):314-320. doi: 10.3892/ol.2019.10280. Epub 2019 Apr 24.
4
miR-296-3p targets APEX1 to suppress cell migration and invasion of non-small-cell lung cancer.
Oncol Lett. 2019 Sep;18(3):2612-2618. doi: 10.3892/ol.2019.10572. Epub 2019 Jul 5.
7
MicroRNA-574-3p inhibits the malignant behavior of liver cancer cells by targeting ADAM28.
Oncol Lett. 2020 Sep;20(3):3015-3023. doi: 10.3892/ol.2020.11852. Epub 2020 Jul 10.
9
MicroRNA-126-3p suppresses cell proliferation by targeting PIK3R2 in Kaposi's sarcoma cells.
Oncotarget. 2016 Jun 14;7(24):36614-36621. doi: 10.18632/oncotarget.9311.

引用本文的文献

1
Emerging implications of N6-methyladenosine in prostate cancer progression and treatment.
Cell Death Discov. 2025 Aug 19;11(1):391. doi: 10.1038/s41420-025-02680-w.
2
The prognostic value of mitogen-activated protein kinase kinase in liver hepatocellular carcinoma by bioinformatics.
Medicine (Baltimore). 2025 Jun 27;104(26):e42933. doi: 10.1097/MD.0000000000042933.
4
Circ_0000069 promotes the development of hepatocellular carcinoma by regulating CCL25.
BMC Cancer. 2024 Jul 11;24(1):827. doi: 10.1186/s12885-024-12594-y.
5
Exploring the impact of circRNAs on cancer glycolysis: Insights into tumor progression and therapeutic strategies.
Noncoding RNA Res. 2024 May 5;9(3):970-994. doi: 10.1016/j.ncrna.2024.05.001. eCollection 2024 Sep.
6
The emerging roles and mechanism of N6-methyladenosine (mA) modifications in urologic tumours progression.
Front Pharmacol. 2023 May 22;14:1192495. doi: 10.3389/fphar.2023.1192495. eCollection 2023.
7
DARS-AS1 modulates cell proliferation and migration of gastric cancer cells by regulating miR-330-3p/NAT10 axis.
Open Med (Wars). 2022 Dec 13;17(1):2036-2045. doi: 10.1515/med-2022-0583. eCollection 2022.
9
An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma.
Biosensors (Basel). 2022 Oct 6;12(10):831. doi: 10.3390/bios12100831.

本文引用的文献

1
Circulating microRNAs as potential biomarkers of HBV infection persistence.
Infect Genet Evol. 2017 Oct;54:152-157. doi: 10.1016/j.meegid.2017.06.023. Epub 2017 Jun 23.
4
MicroRNA-616 promotes the migration, invasion and epithelial-mesenchymal transition of HCC by targeting PTEN.
Oncol Rep. 2016 Jan;35(1):366-74. doi: 10.3892/or.2015.4334. Epub 2015 Oct 16.
5
MiR-335 acts as a potential tumor suppressor miRNA via downregulating ROCK1 expression in hepatocellular carcinoma.
Tumour Biol. 2015 Aug;36(8):6313-9. doi: 10.1007/s13277-015-3317-2. Epub 2015 Mar 25.
7
A role for microRNA-155 expression in microenvironment associated to HPV-induced carcinogenesis in K14-HPV16 transgenic mice.
PLoS One. 2015 Jan 27;10(1):e0116868. doi: 10.1371/journal.pone.0116868. eCollection 2015.
9
Comparison of microRNA expression profiles in HCC-derived microvesicles and the parental cells and evaluation of their roles in HCC.
J Huazhong Univ Sci Technolog Med Sci. 2013 Jun;33(3):346-352. doi: 10.1007/s11596-013-1122-y. Epub 2013 Jun 17.
10
MicroRNA-200a/b influenced the therapeutic effects of curcumin in hepatocellular carcinoma (HCC) cells.
Tumour Biol. 2013 Oct;34(5):3209-18. doi: 10.1007/s13277-013-0891-z. Epub 2013 Jun 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验